Mounjaro, or tirzepatide, activates two related hormone pathways: GLP-1 and GIP
Yilmaz R, Akoglu H, Altun B, Yildirim T, Arici M, Erdem Y
Neural Pathways and Weight Loss: Semaglutide modulates food preference, reduces food intake, and causes weight loss without decreasing energy expenditure by interacting with the brain through several pathways involved in food intake and energy expenditure (Gabery et al., 2020)
Researchers believe that its appetite regulation is achieved through hypothalamic stimulation as well as slowed gastric emptying [7]
Slows gastric emptying: Delays nutrient absorption and moderates postprandial glucose excursions 1,3
Real-world injectable weight loss study